139 related articles for article (PubMed ID: 34048365)
1. MECHANISMS IN ENDOCRINOLOGY: Transient juvenile hypoglycemia in growth hormone receptor deficiency - mechanistic insights from Laron syndrome and tailored animal models.
Hinrichs A; Renner S; Bidlingmaier M; Kopchick JJ; Wolf E
Eur J Endocrinol; 2021 Jul; 185(2):R35-R47. PubMed ID: 34048365
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone receptor-deficient pigs resemble the pathophysiology of human Laron syndrome and reveal altered activation of signaling cascades in the liver.
Hinrichs A; Kessler B; Kurome M; Blutke A; Kemter E; Bernau M; Scholz AM; Rathkolb B; Renner S; Bultmann S; Leonhardt H; de Angelis MH; Nagashima H; Hoeflich A; Blum WF; Bidlingmaier M; Wanke R; Dahlhoff M; Wolf E
Mol Metab; 2018 May; 11():113-128. PubMed ID: 29678421
[TBL] [Abstract][Full Text] [Related]
3. Effects of GHR Deficiency and Juvenile Hypoglycemia on Immune Cells of a Porcine Model for Laron Syndrome.
Schilloks MC; Giese IM; Hinrichs A; Korbonits L; Hauck SM; Wolf E; Deeg CA
Biomolecules; 2023 Mar; 13(4):. PubMed ID: 37189345
[TBL] [Abstract][Full Text] [Related]
4. Generation of a miniature pig disease model for human Laron syndrome.
Cui D; Li F; Li Q; Li J; Zhao Y; Hu X; Zhang R; Li N
Sci Rep; 2015 Oct; 5():15603. PubMed ID: 26511035
[TBL] [Abstract][Full Text] [Related]
5. Transgenic Wuzhishan minipigs designed to express a dominant-negative porcine growth hormone receptor display small stature and a perturbed insulin/IGF-1 pathway.
Li F; Li Y; Liu H; Zhang X; Liu C; Tian K; Bolund L; Dou H; Yang W; Yang H; Staunstrup NH; Du Y
Transgenic Res; 2015 Dec; 24(6):1029-42. PubMed ID: 26510874
[TBL] [Abstract][Full Text] [Related]
6. Generation of GHR-modified pigs as Laron syndrome models via a dual-sgRNAs/Cas9 system and somatic cell nuclear transfer.
Yu H; Long W; Zhang X; Xu K; Guo J; Zhao H; Li H; Qing Y; Pan W; Jia B; Zhao HY; Huang X; Wei HJ
J Transl Med; 2018 Feb; 16(1):41. PubMed ID: 29482569
[TBL] [Abstract][Full Text] [Related]
7. GH Receptor Deficiency in Ecuadorian Adults Is Associated With Obesity and Enhanced Insulin Sensitivity.
Guevara-Aguirre J; Rosenbloom AL; Balasubramanian P; Teran E; Guevara-Aguirre M; Guevara C; Procel P; Alfaras I; De Cabo R; Di Biase S; Narvaez L; Saavedra J; Longo VD
J Clin Endocrinol Metab; 2015 Jul; 100(7):2589-96. PubMed ID: 25985182
[TBL] [Abstract][Full Text] [Related]
8. Functional changes of the liver in the absence of growth hormone (GH) action - Proteomic and metabolomic insights from a GH receptor deficient pig model.
Riedel EO; Hinrichs A; Kemter E; Dahlhoff M; Backman M; Rathkolb B; Prehn C; Adamski J; Renner S; Blutke A; de Angelis MH; Bidlingmaier M; Schopohl J; Arnold GJ; Fröhlich T; Wolf E
Mol Metab; 2020 Jun; 36():100978. PubMed ID: 32277923
[TBL] [Abstract][Full Text] [Related]
9. Despite higher body fat content, Ecuadorian subjects with Laron syndrome have less insulin resistance and lower incidence of diabetes than their relatives.
Guevara-Aguirre J; Procel P; Guevara C; Guevara-Aguirre M; Rosado V; Teran E
Growth Horm IGF Res; 2016 Jun; 28():76-8. PubMed ID: 26259979
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone receptor deficiency in humans associates to obesity, increased body fat percentage, a healthy brain and a coordinated insulin sensitivity.
Guevara-Aguirre J; Teran E; Lescano D; Guevara A; Guevara C; Longo V; Gavilanes AWD
Growth Horm IGF Res; 2020 Apr; 51():58-64. PubMed ID: 32145513
[TBL] [Abstract][Full Text] [Related]
11. Brain Structure and Function Associated with Younger Adults in Growth Hormone Receptor-Deficient Humans.
Nashiro K; Guevara-Aguirre J; Braskie MN; Hafzalla GW; Velasco R; Balasubramanian P; Wei M; Thompson PM; Mather M; Nelson MD; Guevara A; Teran E; Longo VD
J Neurosci; 2017 Feb; 37(7):1696-1707. PubMed ID: 28073935
[TBL] [Abstract][Full Text] [Related]
12. Structural and proteomic repercussions of growth hormone receptor deficiency on the pituitary gland: Lessons from a translational pig model.
Shashikadze B; Franzmeier S; Hofmann I; Kraetzl M; Flenkenthaler F; Blutke A; Fröhlich T; Wolf E; Hinrichs A
J Neuroendocrinol; 2023 Apr; ():e13277. PubMed ID: 37160285
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone insensitivity and adipose tissue: tissue morphology and transcriptome analyses in pigs and humans.
Young JA; Hinrichs A; Bell S; Geitgey DK; Hume-Rivera D; Bounds A; Soneson M; Laron Z; Yaron-Shaminsky D; Wolf E; List EO; Kopchick JJ; Berryman DE
Pituitary; 2023 Dec; 26(6):660-674. PubMed ID: 37747600
[TBL] [Abstract][Full Text] [Related]
14. Reduced levels of thyroid hormones, insulin, and glucose, and lower body core temperature in the growth hormone receptor/binding protein knockout mouse.
Hauck SJ; Hunter WS; Danilovich N; Kopchick JJ; Bartke A
Exp Biol Med (Maywood); 2001 Jun; 226(6):552-8. PubMed ID: 11395925
[TBL] [Abstract][Full Text] [Related]
15. Clinical and Molecular Features of Laron Syndrome, A Genetic Disorder Protecting from Cancer.
Janecka A; Kołodziej-Rzepa M; Biesaga B
In Vivo; 2016; 30(4):375-81. PubMed ID: 27381597
[TBL] [Abstract][Full Text] [Related]
16. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse).
Zhou Y; Xu BC; Maheshwari HG; He L; Reed M; Lozykowski M; Okada S; Cataldo L; Coschigamo K; Wagner TE; Baumann G; Kopchick JJ
Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13215-20. PubMed ID: 9371826
[TBL] [Abstract][Full Text] [Related]
17. Normal intelligence with severe insulin-like growth factor I deficiency due to growth hormone receptor deficiency: a controlled study in a genetically homogeneous population.
Kranzler JH; Rosenbloom AL; Martinez V; Guevara-Aguirre J
J Clin Endocrinol Metab; 1998 Jun; 83(6):1953-8. PubMed ID: 9626125
[TBL] [Abstract][Full Text] [Related]
18. Fifty seven years of follow-up of the Israeli cohort of Laron Syndrome patients-From discovery to treatment.
Laron Z; Kauli R
Growth Horm IGF Res; 2016 Jun; 28():53-6. PubMed ID: 26307357
[TBL] [Abstract][Full Text] [Related]
19. Effects of heterozygosity for the E180 splice mutation causing growth hormone receptor deficiency in Ecuador on IGF-I, IGFBP-3, and stature.
Guevara-Aguirre J; Rosenbloom AL; Guevara-Aguirre M; Yariz K; Saavedra J; Baumbach L; Shuster J
Growth Horm IGF Res; 2007 Jun; 17(3):261-4. PubMed ID: 17350302
[TBL] [Abstract][Full Text] [Related]
20. Insights from the clinical phenotype of subjects with Laron syndrome in Ecuador.
Guevara-Aguirre J; Bautista C; Torres C; Peña G; Guevara C; Palacios C; Guevara A; Gavilanes AWD
Rev Endocr Metab Disord; 2021 Mar; 22(1):59-70. PubMed ID: 33047268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
